Key result
Recombinant apo(a) expressed in mammalian cells yields ~500 kDa protein that forms lipoprotein particles with apoB-100.
Answers are grounded in this paper and cite their sources.
We have stably expressed a recombinant form of apo(a) in a human embryonic kidney cell line. The engineered protein (predicted mass of 250 kDa) contains 17 copies of the apo(a) domain, which resembles kringle 4 of plasminogen, followed by the plasminogen-like kringle 5 and protease-like domain of apo(a). The recombinant protein [r-apo(a)] was isolated from cell culture media by immunoaffinity chromatography, and its physical properties were studied. As is the case for apo(a) isolated from plasma-derived Lp(a), r-apo(a) is highly glycosylated (23% by weight), containing both N- and O-linked glycans, which results in an observed molecular mass of 500 kDa by SDS-PAGE. The high sialic acid content was reflected in a pI of 4.3 for the r-apo(a). Two subpopulations of r-apo(a) secreted by the permanent cell line were identified with respect to lysine-Sepharose binding; the majority of the r-apo(a) bound specifically to this matrix and was eluted with epsilon-aminocaproic acid (epsilon-ACA). When the r-apo(a) plasmid was used to transfect a human hepatoma cell line, lipoprotein particles were secreted containing the disulfide-linked complex of apoB-100 and the r-apo(a). The density of these particles was shown to be heterogeneous, with the majority of the r-Lp(a) floating in the density range of plasma-derived Lp(a).
No takes yet. Share an insight, caveat, or question.
Koschinsky et al. (1991) studied this question. Recombinant apo(a) expression vs. Plasma-derived Lp(a) was evaluated on Physical properties and characterization of r-apo(a). Expression of recombinant apo(a) in mammalian cells produced a 500 kDa protein, glycosylated at 23% by weight, which forms lipoprotein particles when co-expressed with apoB-100.
Synapse has enriched 10 related papers. Consider them for comparative context: